Johnson & Johnson JNJ announced that the FDA has approved its supplemental new drug application (sNDA), seeking approval for ...

The FDA approved Johnson & Johnson’s Spravato nasal spray as a stand-alone treatment for patients suffering from severe ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD.

A pregnant woman seeking a medication abortion in Nebraska would be required under a new bill to attend an in-person appointment with her physician before receiving the drugs and a follow-up ...

Spravato is a first-of-its-kind medication to help manage treatment-resistant depression, according to Johnson & Johnson.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

It's become increasingly clear that the gut microbiome can affect human health, including mental health. Which bacterial ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...

But many people who take daily medications are unaware that certain drugs in their pill box can also increase their risk of ...

A panel of Colorado lawmakers approved a bill that would legalize synthetic psilocybin medications for certain conditions, contingent upon approval by the FDA.

J&J agreed to buy Intra-Cellular Therapies in a deal worth $14.6 billion, another sign of reentry into neuroscience by large ...